Novel paradigms for drug discovery: computational multitarget screening.

ABSTRACT: An established paradigm in current drug development is (i) to identify a single protein target whose inhibition is likely to result in the successful treatment of a disease of interest; (ii) to assay experimentally large libraries of small-molecule compounds in vitro and in vivo to identify promising inhibitors in model systems; and (iii) to determine whether the findings are extensible to humans. This complex process, which is largely based on trial and error, is risk-, time- and cost-intensive. Computational (virtual) screening of drug-like compounds simultaneously against the atomic structures of multiple protein targets, taking into account protein-inhibitor dynamics, might help to identify lead inhibitors more efficiently, particularly for complex drug-resistant diseases. Here we disc

SUBMITTER: Jenwitheesuk E 

PROVIDER: S-EPMC4551513 | biostudies-literature | 2008 Feb

REPOSITORIES: biostudies-literature